Delivering a Complex Integrated Summary of Effectiveness: Efficient Pooling and Advanced Analysis Across Four Multiple Sclerosis Spasticity Studies 

1 minute read

Published: November 17th, 2025

A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mid-project to a new SDTM-level pooling strategy. Unique baseline derivations, advanced analyses, and regulatory expectations added further complexity.

Solution
Phastar introduced a modular workflow separating statistical analysis from TFL production. This streamlined process reduced run times, improved efficiency, and ensured consistency across all studies.

Outcome
Over 200 high-quality TFLs
Submission-ready Clinical Review Template (CRT)
Robust evaluation of treatment effects across time and subgroups

Download the case study to see how Phastar delivered a complex ISE on time and to regulatory standards.

Related articles

Transforming Uncertainty into Statistical Confidence: Simulation-Driven Design for a First-in-Human Reproductive Therapeutic 

Transforming Uncertainty into Statistical Confidence: Simulation-Driven Design for a First-in-Human Reproductive Therapeutic 

July 20th, 2026 1 minute read

Designing a first-in-human study is challenging. Designing one for a novel reproductive therapy with limited prior da...

Turning Complexity into Regulatory Confidence: Designing a Seamless Phase 2b/3 Strategy for FDA Engagement 

Turning Complexity into Regulatory Confidence: Designing a Seamless Phase 2b/3 Strategy for FDA Engagement 

July 20th, 2026 1 minute read

Accelerating clinical development requires more than speed, it demands a careful balance between innovation, scientif...

Enabling First-in-Human Trial Success: Delivering an Innovative Bayesian Phase I/II Oncology Design 

Enabling First-in-Human Trial Success: Delivering an Innovative Bayesian Phase I/II Oncology Design 

July 20th, 2026 1 minute read

Helping an Emerging Biotech Navigate Complex Clinical Development Preparing for a first-in-human clinical trial prese...